- Joined
- 2 June 2011
- Posts
- 5,341
- Reactions
- 242
I did some research last night and have to admit the DDM is the wrong valuation tool. IMF have only being paying dividends since 2007, there is not sufficient dividend history to make a valuation. I am in agreement with the posters about the future work and potential for growth but I am unable to obtain a basic medium term valuation peg. I am going to file IMF in the "too difficult" basket.
Have you had a look at the convertible notes? You are buying a bond with an option to convert at 1:1, or redeem for $1.65/note. YTM at the moment is about ~7.5%.
Might be an easier way to play it if you think valuing the business is too hard but you still want exposure.
I bought the notes (back in May when you posted this) for more exposure on the chance the shares spike after they release guidance for full year net profit, or release their full year net profit which I expect to be $40 million+.
I don't see any downside risk, but I do see the potential of an upside spike when full year profit is released. Who knows how the market will value ~$40 million profit with the shares a PE ratio of 5. $2 isn't too far fetched IMO.
Not sure about buying the notes now though, there is only 2 payments remaining and currently trading for ~$1.74, so you'll be losing money assuming they repay the full value of $1.65 back in December (which they plan to do) without a spike in the share price above $1.65.
Hi McLovin,
They have the option to pay them back in December 2012 and they indicated in one of the investor presentations this was going to be the most likely option. Anyone buying at the current price of ~$1.74 now will most likely lose money unless the share price spikes up before then and they convert to an ordinary share.
Hi McLovin,
They have the option to pay them back in December 2012 and they indicated in one of the investor presentations this was going to be the most likely option. Anyone buying at the current price of ~$1.74 now will most likely lose money unless the share price spikes up before then and they convert to an ordinary share.
I think IMF are cheaper now than what they were earlier in the year because they have more cash backing it up and book value is now 1.5 if you include the dividend, seeing as they are still trading CD.
Sorry what does 'trading CD' mean?
Some lovely results! Had a big run up into XD too.
My valuation of the company is as follows:
Assets less convertible shares liability = 95 mill
$$ invested = 66 mill
Track record on $$ invest is earning 3 $ for every one $ invested, so expected earnings on the 66 mill = 198 mill.
This to my mind gives a value of ~ 300 mill, or a price per share of $2.15 - not accounting for growth or dividends.
However, growth should compound as the balance sheet gets bigger (can afford to take on more and more cases), as well as moving into the US.
Given lumpiness of earnings, however, I expect the value of IMF to always remain a little lower. Still, I'm happy to hold for the foreseeable future. I'd be interested in other people's thoughts!
I'm holding part free carried positions in both my Super and personal portfolios @ around the $1.35 level...happy to hold and build my position with (LEACA) and collect dividends and credits along the way...i love the business and the instant diversity it brings to a portfolio.
Why did the SP drop so hard when it went ex-div? Buying opportunity? I'll keep watching for now.
After averaging down in the last dip I'm at 1.32 and also happy to hold for the foreseeable future - huge yield and low p/e (still way below my valuation of NTA) makes a good argument - it also seems recession proof and non-cyclical. What was LEACA?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?